Smoking boosts clopidogrel effect in people with diabetes and CAD

04/9/2012 | Medscape (free registration)

Data on 134 patients with type 2 diabetes and coronary artery disease who were on maintenance clopidogrel therapy showed that those who smoked were less likely to suffer from high on-treatment platelet reactivity than nonsmokers. However, researchers warned that cardiovascular events, including mortality, remained higher for smokers. The results were published in JACC: Cardiovascular Interventions.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Clara, CA
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA